Therapeutic (Medical) Cannabis: Fact, Fiction, Guidance, 5/19/22



Date & Location
Thursday, May 19, 2022, 12:00 PM - Sunday, May 18, 2025, 1:00 PM

Credits
AMA PRA Category 1 Credits™ (0.75 hours), CME-Designated Participation Credit (0.75 hours)

Overview

Learners will be able to apply current clinical research and principles of evidence-based medicine to determine clinical diagnoses by formulating and implementing acceptable treatment modalities to their General Internal Medicine practice. 

Presenters
Charles Brackett, MD, MPH
Dartmouth College, Geisel School of Medicine
Population Health, DH

Alan J. Budney, PhD
Dartmouth College, Geisel School of Medicine
Center for Technology and Behavioral Health

Learning Outcome
Learners will be able to discuss the extant data on the clinical efficacy of cannabis compounds and products, and the impact of cannabis industry and legalization on perceptions of cannabis risks and benefits, while identifying the diverse compounds in cannabis products and their effects. 

Disclosure
The following activity director(s), planning committee member(s), speaker(s), author(s) or anyone in a position to control the content for this activity have reported the following financial relationship(s)* with ineligible company(ies)**. All of the relevant financial relationships listed for these individuals have been mitigated.

Alan J. Budney, PhD ~ is on the Science Advisory Board for Canopy Growth, Inc, and has been a consultant for Jazz Pharmaceuticals.

* A “financial relationship" includes employee, researcher (named as the PI), consultant, advisor, speaker, independent contractor (including contracted research), royalties or patent beneficiary, executive role, and/or an ownership interest (not including stocks owned in a managed portfolio).

** An ineligible company is any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Bibliographic Material
See recording for Bibliographic References.


Accreditation

Dartmouth Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. 

Dartmouth Health designates this Enduring Material for a maximum of 0.75 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Registration/Requirements for Successful Completion
You may claim credit for successful completion of this online course. In order to claim credit, you must follow these steps:

  1. Register for the learning activity by creating an account or logging in to your account.
  2. Click Tests and then View Content to view the recording. View the entire presentation.
  3. Complete the Post-Test attestation.
  4. Click My Account in the menu bar; then click Evaluation.
  5. Complete and Submit the Evaluation.

Provider Contact Information
Provider contact information for questions regarding accreditation of the activity:

Center for Learning and Professional Development
CME/CNE Office
Dartmouth Health
[email protected]